METHYLPHENIDATE HYDROCHLORIDE

METHYLPHENIDATE HYDROCHLORIDE was reported 58050 times

These side effects are most commonly reported by patients taking METHYLPHENIDATE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 6038
1 FATIGUE 3126
2 NAUSEA 2924
3 OFF LABEL USE 2897
4 HEADACHE 2883
5 ANXIETY 2741
6 DEPRESSION 2276
7 INSOMNIA 2127
8 SOMNOLENCE 1850
9 DIZZINESS 1771
10 FEELING ABNORMAL 1721
11 VOMITING 1704
12 SUICIDAL IDEATION 1683
13 DECREASED APPETITE 1628
14 WEIGHT DECREASED 1591
15 AGGRESSION 1486
16 CONDITION AGGRAVATED 1470
17 PAIN 1461
18 DISTURBANCE IN ATTENTION 1409
19 MALAISE 1272
20 WEIGHT INCREASED 1262
21 AGITATION 1245
22 DIARRHOEA 1242
23 TOXICITY TO VARIOUS AGENTS 1213
24 HYPERTENSION 1201
25 DYSPNOEA 1176
26 PRODUCT DOSE OMISSION ISSUE 1140
27 FALL 1133
28 ABNORMAL BEHAVIOUR 1131
29 PRODUCT SUBSTITUTION ISSUE 1121
30 ASTHENIA 1058
31 IRRITABILITY 1044
32 TREMOR 1041
33 DRUG ABUSE 1034
34 DRUG INTERACTION 969
35 TACHYCARDIA 933
36 OVERDOSE 913
37 RASH 904
38 ARTHRALGIA 863
39 BLOOD PRESSURE INCREASED 843
40 CONFUSIONAL STATE 822
41 MEMORY IMPAIRMENT 812
42 PYREXIA 802
43 SUICIDE ATTEMPT 798
44 PALPITATIONS 794
45 CHEST PAIN 761
46 ABDOMINAL PAIN UPPER 758
47 PRURITUS 745
48 HYPERHIDROSIS 741
49 HEART RATE INCREASED 740
50 HALLUCINATION 737
51 PAIN IN EXTREMITY 736
52 PRODUCT USE ISSUE 736
53 DRUG DOSE OMISSION 734
54 HOSPITALISATION 718
55 MUSCLE SPASMS 695
56 COUGH 690
57 ABDOMINAL PAIN 684
58 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 682
59 PNEUMONIA 668
60 INTENTIONAL OVERDOSE 661
61 ANGER 659
62 NASOPHARYNGITIS 657
63 MIGRAINE 651
64 GAIT DISTURBANCE 639
65 BACK PAIN 636
66 CONSTIPATION 631
67 HYPOAESTHESIA 628
68 DRUG DEPENDENCE 612
69 LOSS OF CONSCIOUSNESS 603
70 PSYCHOMOTOR HYPERACTIVITY 598
71 PRODUCT USE IN UNAPPROVED INDICATION 597
72 DEATH 596
73 PARAESTHESIA 594
74 INTENTIONAL PRODUCT USE ISSUE 592
75 PRODUCT QUALITY ISSUE 592
76 SLEEP APNOEA SYNDROME 587
77 HYPERSENSITIVITY 580
78 VISION BLURRED 577
79 SLEEP DISORDER 572
80 SEIZURE 564
81 DEPRESSED MOOD 559
82 INCORRECT DOSE ADMINISTERED 555
83 COMPLETED SUICIDE 551
84 PSYCHOTIC DISORDER 543
85 INTENTIONAL PRODUCT MISUSE 534
86 ABDOMINAL DISCOMFORT 528
87 DYSKINESIA 516
88 SURGERY 501
89 PRODUCT AVAILABILITY ISSUE 493
90 SINUSITIS 489
91 STRESS 489
92 WITHDRAWAL SYNDROME 486
93 TIC 485
94 CRYING 476
95 URINARY TRACT INFECTION 468
96 UNEVALUABLE EVENT 467
97 DRUG HYPERSENSITIVITY 463
98 ALOPECIA 462
99 THERAPEUTIC RESPONSE UNEXPECTED 460
100 DRUG EFFECT DECREASED 456
101 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 453
102 RESTLESSNESS 449
103 EMOTIONAL DISORDER 439
104 TREATMENT NONCOMPLIANCE 435
105 PRE-EXISTING CONDITION IMPROVED 428
106 DRY MOUTH 425
107 MUSCULAR WEAKNESS 424
108 HYPOTENSION 422
109 MOOD SWINGS 420
110 INTENTIONAL SELF-INJURY 418
111 PANIC ATTACK 414
112 COVID-19 413
113 URTICARIA 390
114 ASTHMA 384
115 ADVERSE EVENT 382
116 SYNCOPE 378
117 BALANCE DISORDER 375
118 NO ADVERSE EVENT 375
119 DEHYDRATION 372
120 AMNESIA 366
121 MYALGIA 365
122 LETHARGY 363
123 DRUG INTOLERANCE 361
124 VISUAL IMPAIRMENT 358
125 GASTROOESOPHAGEAL REFLUX DISEASE 356
126 ERYTHEMA 352
127 ILLNESS 352
128 MENTAL DISORDER 349
129 GYNAECOMASTIA 348
130 INFLUENZA 348
131 DYSTONIA 338
132 TREATMENT FAILURE 338
133 NERVOUSNESS 335
134 PARANOIA 327
135 CONVULSION 315
136 HALLUCINATION, VISUAL 311
137 PRODUCT ADMINISTRATION INTERRUPTED 310
138 MOOD ALTERED 309
139 THERAPEUTIC RESPONSE DECREASED 308
140 DRUG WITHDRAWAL SYNDROME 304
141 INJECTION SITE PAIN 303
142 ADVERSE DRUG REACTION 302
143 BRONCHITIS 302
144 HALLUCINATION, AUDITORY 302
145 SPEECH DISORDER 302
146 DYSPHAGIA 300
147 SEROTONIN SYNDROME 300
148 EMOTIONAL DISTRESS 299
149 MULTIPLE SCLEROSIS RELAPSE 299
150 DYSPEPSIA 296
151 GASTROINTESTINAL DISORDER 296
152 FLUSHING 294
153 CHEST DISCOMFORT 293
154 ANAEMIA 292
155 COGNITIVE DISORDER 290
156 ELECTROCARDIOGRAM QT PROLONGED 288
157 CONTUSION 287
158 MANIA 280
159 FOETAL EXPOSURE DURING PREGNANCY 278
160 NIGHTMARE 278
161 OROPHARYNGEAL PAIN 278
162 SEDATION 275
163 PERIPHERAL SWELLING 274
164 MYOCARDIAL INFARCTION 272
165 CEREBROVASCULAR ACCIDENT 271
166 CARDIAC ARREST 270
167 INFECTION 263
168 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 262
169 EXPOSURE DURING PREGNANCY 262
170 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 260
171 HYPERSOMNIA 259
172 CHILLS 257
173 THERAPEUTIC PRODUCT EFFECT DECREASED 254
174 ARRHYTHMIA 251
175 OEDEMA PERIPHERAL 251
176 ARTHRITIS 248
177 NEPHROLITHIASIS 244
178 PULMONARY EMBOLISM 244
179 ABDOMINAL DISTENSION 243
180 DIABETES MELLITUS 243
181 ROAD TRAFFIC ACCIDENT 242
182 FEELING JITTERY 241
183 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 240
184 NEUROPATHY PERIPHERAL 236
185 APATHY 235
186 MYDRIASIS 234
187 ATTENTION DEFICIT HYPERACTIVITY DISORDER 233
188 GROWTH RETARDATION 233
189 MUSCULOSKELETAL STIFFNESS 233
190 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 232
191 FEELING HOT 227
192 THERAPEUTIC RESPONSE SHORTENED 226
193 ACNE 225
194 URINARY INCONTINENCE 224
195 BIPOLAR DISORDER 222
196 DRY SKIN 222
197 SOMNAMBULISM 220
198 THINKING ABNORMAL 220
199 NECK PAIN 219
200 DEPRESSED LEVEL OF CONSCIOUSNESS 218
201 MUSCLE TWITCHING 216
202 DELUSION 214
203 EPISTAXIS 214
204 DISORIENTATION 213
205 MEDICATION ERROR 208
206 TINNITUS 206
207 INJURY 205
208 VERTIGO 205
209 IMPULSIVE BEHAVIOUR 204
210 INITIAL INSOMNIA 204
211 DYSARTHRIA 203
212 DRUG EFFECT INCOMPLETE 202
213 BLOOD CHOLESTEROL INCREASED 199
214 DISCOMFORT 198
215 RHINORRHOEA 198
216 OBSESSIVE-COMPULSIVE DISORDER 197
217 FEAR 196
218 PRESCRIBED OVERDOSE 196
219 BLOOD GLUCOSE INCREASED 195
220 AFFECT LABILITY 194
221 INFLUENZA LIKE ILLNESS 194
222 CARDIO-RESPIRATORY ARREST 193
223 INCREASED APPETITE 193
224 POOR QUALITY SLEEP 193
225 SWELLING 193
226 NASAL CONGESTION 191
227 EATING DISORDER 190
228 PRODUCT DOSE OMISSION 190
229 BLOOD PRESSURE DECREASED 189
230 TARDIVE DYSKINESIA 187
231 ENURESIS 186
232 RESTLESS LEGS SYNDROME 186
233 WRONG TECHNIQUE IN DRUG USAGE PROCESS 186
234 HEPATIC ENZYME INCREASED 185
235 MENTAL IMPAIRMENT 184
236 EDUCATIONAL PROBLEM 182
237 FIBROMYALGIA 181
238 COMA 180
239 MIDDLE INSOMNIA 179
240 ALANINE AMINOTRANSFERASE INCREASED 178
241 ACUTE KIDNEY INJURY 176
242 DYSGEUSIA 176
243 CATAPLEXY 175
244 HOT FLUSH 175
245 OBESITY 175
246 SWELLING FACE 175
247 ATRIAL FIBRILLATION 174
248 HYPOTHYROIDISM 174
249 POLLAKIURIA 174
250 RENAL FAILURE 172
251 WHITE BLOOD CELL COUNT DECREASED 172
252 BRADYCARDIA 171
253 DEEP VEIN THROMBOSIS 171
254 THERAPY CESSATION 171
255 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 170
256 DRY EYE 169
257 EPILEPSY 169
258 UNRESPONSIVE TO STIMULI 169
259 MULTIPLE SCLEROSIS 168
260 HUNGER 167
261 CARDIAC DISORDER 166
262 NEUTROPENIA 161
263 ABNORMAL DREAMS 159
264 JOINT SWELLING 159
265 POISONING 159
266 SEPSIS 159
267 BLOOD CREATINE PHOSPHOKINASE INCREASED 158
268 INTENTIONAL DOSE OMISSION 158
269 DYSPHONIA 156
270 CATARACT 155
271 EUPHORIC MOOD 155
272 GENERAL PHYSICAL HEALTH DETERIORATION 155
273 DELIRIUM 154
274 ERECTILE DYSFUNCTION 153
275 NIGHT SWEATS 153
276 SUBSTANCE ABUSE 153
277 COLITIS ULCERATIVE 152
278 DIPLOPIA 151
279 RHEUMATOID ARTHRITIS 151
280 BODY TEMPERATURE INCREASED 150
281 RHABDOMYOLYSIS 149
282 HAEMATOCHEZIA 148
283 MENTAL STATUS CHANGES 148
284 HEAD INJURY 147
285 PRODUCT ADHESION ISSUE 147
286 ASPARTATE AMINOTRANSFERASE INCREASED 146
287 EAR INFECTION 146
288 HAEMOGLOBIN DECREASED 146
289 MATERNAL EXPOSURE DURING PREGNANCY 146
290 OSTEOARTHRITIS 146
291 WHEEZING 146
292 CELLULITIS 145
293 DRUG DIVERSION 145
294 EXTRAPYRAMIDAL DISORDER 144
295 INTENTIONAL DRUG MISUSE 144
296 PERSONALITY CHANGE 144
297 DRUG EFFECT LESS THAN EXPECTED 143
298 HAEMORRHAGE 143
299 PALLOR 141
300 EYE PAIN 140
301 HEART RATE DECREASED 140
302 INTERVERTEBRAL DISC PROTRUSION 140
303 SEASONAL ALLERGY 140
304 APHASIA 139
305 MAJOR DEPRESSION 139
306 MOVEMENT DISORDER 139
307 FLUID RETENTION 138
308 MOBILITY DECREASED 138
309 UPPER RESPIRATORY TRACT INFECTION 138
310 DRUG TOLERANCE 136
311 THROMBOCYTOPENIA 136
312 BURNING SENSATION 135
313 DEVICE ISSUE 135
314 FOOT FRACTURE 135
315 SKIN EXFOLIATION 135
316 THROMBOSIS 135
317 RETCHING 134
318 STOMATITIS 134
319 ACCIDENTAL OVERDOSE 133
320 AFFECTIVE DISORDER 133
321 DRUG PRESCRIBING ERROR 133
322 CHRONIC KIDNEY DISEASE 132
323 ACUTE MYOCARDIAL INFARCTION 131
324 BRUXISM 131
325 VIRAL INFECTION 131
326 THERAPY NON-RESPONDER 130
327 PLATELET COUNT DECREASED 129
328 TRISMUS 129
329 AKATHISIA 128
330 DISEASE PROGRESSION 128
331 MUSCULOSKELETAL PAIN 128
332 LOGORRHOEA 126
333 SOCIAL AVOIDANT BEHAVIOUR 126
334 URINARY RETENTION 126
335 PRODUCT TASTE ABNORMAL 125
336 ANAPHYLACTIC REACTION 124
337 COELIAC DISEASE 124
338 MALIGNANT NEOPLASM PROGRESSION 124
339 SKIN DISCOLOURATION 124
340 ACTIVITIES OF DAILY LIVING IMPAIRED 122
341 INFUSION RELATED REACTION 122
342 PRODUCT PHYSICAL ISSUE 122
343 PSORIASIS 122
344 DISSOCIATION 121
345 ECZEMA 121
346 LIMB INJURY 121
347 OEDEMA 120
348 ANOREXIA 119
349 SCREAMING 119
350 ARTHROPATHY 118
351 NARCOLEPSY 117
352 TYPE 2 DIABETES MELLITUS 116
353 DRUG USE DISORDER 115
354 PRODUCTIVE COUGH 115
355 THIRST 115
356 UNDERDOSE 115
357 ANGINA PECTORIS 114
358 HYPOPHAGIA 114
359 IMPAIRED WORK ABILITY 114
360 THERAPY INTERRUPTED 114
361 DISABILITY 113
362 DYSURIA 113
363 HYPOKALAEMIA 113
364 WHITE BLOOD CELL COUNT INCREASED 113
365 DERMATITIS ATOPIC 112
366 HERPES ZOSTER 112
367 EYE DISORDER 111
368 HOMICIDAL IDEATION 111
369 PERIPHERAL COLDNESS 111
370 AUTISM SPECTRUM DISORDER 110
371 NEURALGIA 110
372 SNORING 110
373 THROAT IRRITATION 110
374 BRAIN FOG 109
375 COORDINATION ABNORMAL 109
376 THERAPEUTIC RESPONSE CHANGED 109
377 FEELING COLD 108
378 BEHAVIOUR DISORDER 107
379 DRUG ADMINISTRATION ERROR 107
380 FLATULENCE 107
381 PANCREATITIS 107
382 LYMPHADENOPATHY 106
383 MUSCLE TIGHTNESS 106
384 RESPIRATORY FAILURE 106
385 VISUAL ACUITY REDUCED 106
386 INJECTION SITE ERYTHEMA 105
387 LIMB DISCOMFORT 105
388 POST-TRAUMATIC STRESS DISORDER 105
389 PRODUCT DISPENSING ERROR 105
390 SINUS TACHYCARDIA 105
391 ABORTION SPONTANEOUS 104
392 CROHN^S DISEASE 104
393 IRRITABLE BOWEL SYNDROME 104
394 PHARMACEUTICAL PRODUCT COMPLAINT 104
395 SUICIDAL BEHAVIOUR 104
396 DISTURBANCE IN SOCIAL BEHAVIOUR 103
397 ILL-DEFINED DISORDER 103
398 INCORRECT ROUTE OF DRUG ADMINISTRATION 103
399 PULMONARY OEDEMA 103
400 GAIT INABILITY 102
401 HYPOXIA 102
402 ACCIDENTAL EXPOSURE TO PRODUCT 101
403 INSURANCE ISSUE 101
404 ORAL HERPES 101
405 OSTEOPOROSIS 101
406 BLOOD PRESSURE FLUCTUATION 100
407 CHOLELITHIASIS 100
408 CYANOSIS 100
409 HYPOKINESIA 99
410 PANIC REACTION 99
411 FEELING DRUNK 98
412 HEPATIC STEATOSIS 98
413 ALTERED STATE OF CONSCIOUSNESS 97
414 APPLICATION SITE ERYTHEMA 97
415 BLOOD POTASSIUM DECREASED 97
416 INFLAMMATION 97
417 PLEURAL EFFUSION 97
418 DRUG DOSE OMISSION BY DEVICE 96
419 GASTROENTERITIS VIRAL 96
420 RESPIRATORY DISORDER 96
421 RIB FRACTURE 96
422 BLISTER 95
423 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 95
424 DRUG LEVEL INCREASED 95
425 HYPOGLYCAEMIA 94
426 PRE-ECLAMPSIA 94
427 SKIN DISORDER 94
428 GENERALISED TONIC-CLONIC SEIZURE 93
429 LEUKOPENIA 93
430 OCULAR HYPERAEMIA 93
431 DYSSTASIA 92
432 IMPAIRED DRIVING ABILITY 92
433 RESPIRATORY ARREST 92
434 SWOLLEN TONGUE 92
435 HEAD DISCOMFORT 90
436 HYPONATRAEMIA 90
437 INJECTION SITE BRUISING 90
438 LIP SWELLING 90
439 OXYGEN SATURATION DECREASED 90
440 PNEUMONIA ASPIRATION 90
441 RENAL IMPAIRMENT 90
442 BONE PAIN 89
443 DISEASE RECURRENCE 89
444 HAEMATURIA 89
445 LIBIDO DECREASED 89
446 NERVOUS SYSTEM DISORDER 89
447 SCHIZOPHRENIA 89
448 CARDIAC FAILURE 88
449 HEART RATE IRREGULAR 88
450 HYPERGLYCAEMIA 88
451 REBOUND EFFECT 88
452 ANGIOEDEMA 87
453 DYSPNOEA EXERTIONAL 87
454 GASTRIC DISORDER 87
455 VAGINAL HAEMORRHAGE 87
456 ANHEDONIA 86
457 DRUG DISPENSING ERROR 86
458 DRUG EXPOSURE DURING PREGNANCY 86
459 LYMPHOCYTE COUNT DECREASED 86
460 RASH ERYTHEMATOUS 86
461 BLOOD CREATININE INCREASED 85
462 DEVICE BREAKAGE 85
463 DRUG SCREEN POSITIVE 85
464 PAIN IN JAW 85
465 PRIAPISM 85
466 RAYNAUD^S PHENOMENON 85
467 SENSORY DISTURBANCE 85
468 SINUS DISORDER 85
469 BRAIN OEDEMA 84
470 COLITIS 84
471 ATAXIA 83
472 CONCUSSION 83
473 EYE SWELLING 83
474 HYPERPROLACTINAEMIA 83
475 INJECTION SITE REACTION 83
476 JOINT INJURY 83
477 KIDNEY INFECTION 83
478 SEXUAL DYSFUNCTION 83
479 TACHYPNOEA 83
480 BRAIN INJURY 82
481 CONTRAINDICATED PRODUCT ADMINISTERED 82
482 CYSTITIS 82
483 EXTRA DOSE ADMINISTERED 82
484 INJECTION SITE PRURITUS 82
485 PSYCHIATRIC SYMPTOM 82
486 STAPHYLOCOCCAL INFECTION 82
487 TOOTH DISORDER 82
488 WOUND 82
489 CARDIAC VALVE DISEASE 81
490 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 81
491 EYE IRRITATION 81
492 RASH PRURITIC 81
493 ANKLE FRACTURE 80
494 FEBRILE NEUTROPENIA 80
495 TERMINAL INSOMNIA 80
496 FORMICATION 79
497 MATERNAL EXPOSURE DURING BREAST FEEDING 79
498 ORAL PAIN 79
499 PHOTOPHOBIA 79
500 GRAND MAL CONVULSION 78
501 MYOCARDITIS 78
502 RECTAL HAEMORRHAGE 78
503 STATUS EPILEPTICUS 78
504 STEVENS-JOHNSON SYNDROME 78
505 VITAMIN D DEFICIENCY 78
506 ARTERIOSCLEROSIS CORONARY ARTERY 77
507 BLINDNESS 77
508 CHOREOATHETOSIS 77
509 HYPERKINESIA 77
510 PRODUCT DOSE OMISSION IN ERROR 77
511 PRODUCT USE COMPLAINT 77
512 TRANSIENT ISCHAEMIC ATTACK 77
513 BLOOD PRESSURE ABNORMAL 76
514 DRUG SCREEN NEGATIVE 76
515 GLAUCOMA 76
516 IMPAIRED GASTRIC EMPTYING 76
517 NEUROLEPTIC MALIGNANT SYNDROME 76
518 NOCTURIA 76
519 SELF-INJURIOUS IDEATION 76
520 THROAT TIGHTNESS 76
521 HYPOACUSIS 75
522 PRESYNCOPE 75
523 PRODUCT COLOUR ISSUE 75
524 PRODUCT STORAGE ERROR 75
525 SKIN LESION 75
526 DEAFNESS 74
527 HYPERPHAGIA 74
528 LIGAMENT SPRAIN 74
529 MUSCULOSKELETAL DISCOMFORT 74
530 PANCREATITIS ACUTE 74
531 BLOOD GLUCOSE DECREASED 73
532 CARDIAC FAILURE CONGESTIVE 73
533 CARDIOVASCULAR DISORDER 73
534 CHOLECYSTECTOMY 73
535 FUNGAL INFECTION 73
536 GASTRITIS 73
537 PRODUCT FORMULATION ISSUE 73
538 RESPIRATORY DEPRESSION 73
539 RESPIRATORY TRACT INFECTION 73
540 ABNORMAL WEIGHT GAIN 72
541 HANGOVER 72
542 RENAL DISORDER 72
543 THERAPY PARTIAL RESPONDER 72
544 BLOOD ALKALINE PHOSPHATASE INCREASED 71
545 HALLUCINATIONS, MIXED 71
546 HYPERVENTILATION 71
547 MENSTRUATION IRREGULAR 71
548 SKIN IRRITATION 71
549 SLUGGISHNESS 71
550 FREQUENT BOWEL MOVEMENTS 70
551 LIVER FUNCTION TEST ABNORMAL 70
552 METABOLIC ACIDOSIS 70
553 PRODUCT PRESCRIBING ERROR 70
554 PSORIATIC ARTHROPATHY 70
555 SUBSTANCE USE DISORDER 70
556 TOOTHACHE 70
557 AMENORRHOEA 69
558 BACK DISORDER 69
559 BACK INJURY 69
560 CEREBRAL HAEMORRHAGE 69
561 RESPIRATORY DISTRESS 69
562 APPETITE DISORDER 68
563 CEREBRAL INFARCTION 68
564 DECREASED INTEREST 68
565 FRUSTRATION TOLERANCE DECREASED 68
566 HAEMATOCRIT DECREASED 68
567 INJECTION SITE SWELLING 68
568 INTRACRANIAL PRESSURE INCREASED 68
569 RED BLOOD CELL COUNT DECREASED 68
570 SKIN BURNING SENSATION 68
571 ANAL INCONTINENCE 67
572 BLOOD TRIGLYCERIDES INCREASED 67
573 LUNG DISORDER 67
574 MOUTH ULCERATION 67
575 PETIT MAL EPILEPSY 67
576 PULMONARY MALFORMATION 67
577 SCAR 67
578 SUDDEN DEATH 67
579 TACHYPHRENIA 67
580 ABASIA 66
581 HYPERTHYROIDISM 66
582 INABILITY TO AFFORD MEDICATION 66
583 INTERVERTEBRAL DISC DEGENERATION 66
584 MITRAL VALVE INCOMPETENCE 66
585 MUSCLE RIGIDITY 66
586 PRODUCT INEFFECTIVE 66
587 QUALITY OF LIFE DECREASED 66
588 SCOLIOSIS 66
589 THERAPEUTIC PRODUCT EFFECT VARIABLE 66
590 THYROID DISORDER 66
591 EXPOSURE VIA BREAST MILK 65
592 HAEMORRHOIDS 65
593 IMPAIRED QUALITY OF LIFE 65
594 INTESTINAL OBSTRUCTION 65
595 PULMONARY HYPERTENSION 65
596 SELF INJURIOUS BEHAVIOUR 65
597 SUPRAVENTRICULAR TACHYCARDIA 65
598 ACCIDENT 64
599 BLOOD PRESSURE SYSTOLIC INCREASED 64
600 COLD SWEAT 64
601 DRUG-INDUCED LIVER INJURY 64
602 FEEDING DISORDER 64
603 LACRIMATION INCREASED 64
604 MICTURITION URGENCY 64
605 PANCYTOPENIA 64
606 SCIATICA 64
607 SELF-DESTRUCTIVE BEHAVIOUR 64
608 BLOOD BILIRUBIN INCREASED 63
609 CARPAL TUNNEL SYNDROME 63
610 CHOKING 63
611 DISTRACTIBILITY 63
612 EYE MOVEMENT DISORDER 63
613 FRACTURE 63
614 OSTEOPENIA 63
615 ARTERIOSPASM CORONARY 62
616 CIRCULATORY COLLAPSE 62
617 EAR PAIN 62
618 HIP FRACTURE 62
619 JOINT STIFFNESS 62
620 MUSCLE SPASTICITY 62
621 PRODUCT PACKAGING QUANTITY ISSUE 62
622 BRADYPHRENIA 61
623 DEPENDENCE 61
624 INCONTINENCE 61
625 MYOCLONUS 61
626 RENAL FAILURE ACUTE 61
627 ROTATOR CUFF SYNDROME 61
628 EXPIRED PRODUCT ADMINISTERED 60
629 FOOD ALLERGY 60
630 HYPOMANIA 60
631 KNEE ARTHROPLASTY 60
632 PERFORMANCE STATUS DECREASED 60
633 SALIVARY HYPERSECRETION 60
634 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 60
635 UPPER LIMB FRACTURE 60
636 BONE DISORDER 59
637 CARDIOMYOPATHY 59
638 HYSTERECTOMY 59
639 IMPAIRED HEALING 59
640 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59
641 DENTAL CARIES 58
642 HYPOAESTHESIA ORAL 58
643 POOR QUALITY DRUG ADMINISTERED 58
644 PRODUCT PREPARATION ERROR 58
645 LIVER INJURY 57
646 MENORRHAGIA 57
647 RASH MACULAR 57
648 SINUS CONGESTION 57
649 SLEEP-RELATED EATING DISORDER 57
650 SPINAL OPERATION 57
651 TENSION 57
652 TOOTH EXTRACTION 57
653 VITAMIN D DECREASED 57
654 BACTERIAL INFECTION 56
655 BLADDER DISORDER 56
656 DRUG ABUSER 56
657 MOTOR DYSFUNCTION 56
658 PREGNANCY 56
659 TRICHOTILLOMANIA 56
660 WEIGHT GAIN POOR 56
661 DERMATITIS CONTACT 55
662 ECONOMIC PROBLEM 55
663 GALACTORRHOEA 55
664 GLOSSODYNIA 55
665 JAUNDICE 55
666 LIVER DISORDER 55
667 LOWER LIMB FRACTURE 55
668 PHARYNGITIS STREPTOCOCCAL 55
669 BREAST CANCER 54
670 DRUG TOXICITY 54
671 GASTROINTESTINAL HAEMORRHAGE 54
672 POISONING DELIBERATE 54
673 PRODUCT ADMINISTRATION ERROR 54
674 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 54
675 SLEEP PARALYSIS 54
676 ELECTROCARDIOGRAM ABNORMAL 53
677 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 53
678 EYE PRURITUS 53
679 HAEMATEMESIS 53
680 IMPULSE-CONTROL DISORDER 53
681 INCOHERENT 53
682 OBSESSIVE THOUGHTS 53
683 CARDIAC MURMUR 52
684 CLOSTRIDIUM DIFFICILE INFECTION 52
685 GALLBLADDER DISORDER 52
686 HYPERTHERMIA 52
687 INCORRECT DRUG ADMINISTRATION DURATION 52
688 KNEE OPERATION 52
689 PRECOCIOUS PUBERTY 52
690 SNEEZING 52
691 TEMPERATURE INTOLERANCE 52
692 THERAPY CHANGE 52
693 APNOEA 51
694 BODY TEMPERATURE DECREASED 51
695 CENTRAL NERVOUS SYSTEM LESION 51
696 DEPRESSIVE SYMPTOM 51
697 DERMATITIS 51
698 DIVERTICULITIS 51
699 KOUNIS SYNDROME 51
700 MUSCLE CONTRACTURE 51
701 NEUTROPHIL COUNT DECREASED 51
702 TENDONITIS 51
703 DRUG LEVEL DECREASED 50
704 OPPOSITIONAL DEFIANT DISORDER 50
705 ORTHOSTATIC HYPOTENSION 50
706 RASH GENERALISED 50
707 STREPTOCOCCAL INFECTION 50
708 ABNORMAL SLEEP-RELATED EVENT 49
709 BLOOD URINE PRESENT 49
710 DEVICE MALFUNCTION 49
711 HIATUS HERNIA 49
712 INJECTION SITE HAEMORRHAGE 49
713 NEGATIVE THOUGHTS 49
714 NYSTAGMUS 49
715 PANIC DISORDER 49
716 PHOTOSENSITIVITY REACTION 49
717 SUBSTANCE USE 49
718 TOOTH INFECTION 49
719 VENTRICULAR TACHYCARDIA 49
720 APPENDICITIS 48
721 C-REACTIVE PROTEIN INCREASED 48
722 DEVICE LEAKAGE 48
723 EXOSTOSIS 48
724 GASTRIC ULCER 48
725 HEMIPARESIS 48
726 LABORATORY TEST ABNORMAL 48
727 LOWER RESPIRATORY TRACT INFECTION 48
728 PARASOMNIA 48
729 PHARYNGEAL OEDEMA 48
730 PNEUMONITIS 48
731 POST PROCEDURAL COMPLICATION 48
732 PROCEDURAL PAIN 48
733 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 48
734 TOOTH LOSS 48
735 VENTRICULAR EXTRASYSTOLES 48
736 APPLICATION SITE IRRITATION 47
737 CYST 47
738 DRUG RESISTANCE 47
739 GLUCOSE TOLERANCE IMPAIRED 47
740 HEPATIC FUNCTION ABNORMAL 47
741 METABOLIC DISORDER 47
742 RESPIRATORY RATE INCREASED 47
743 SKIN LACERATION 47
744 SYSTEMIC LUPUS ERYTHEMATOSUS 47
745 TOURETTE^S DISORDER 47
746 TRANSAMINASES INCREASED 47
747 CATATONIA 46
748 CHROMATURIA 46
749 DEMENTIA 46
750 DROOLING 46
751 ENCEPHALOPATHY 46
752 GASTROENTERITIS 46
753 MUSCLE STRAIN 46
754 MUSCULOSKELETAL DISORDER 46
755 PHARYNGITIS 46
756 PNEUMOTHORAX 46
757 SOCIAL ANXIETY DISORDER 46
758 ABSCESS 45
759 APHONIA 45
760 CORONARY ARTERY DISEASE 45
761 DYSPHEMIA 45
762 ENERGY INCREASED 45
763 HAEMOPTYSIS 45
764 HERNIA 45
765 NERVE COMPRESSION 45
766 PARALYSIS 45
767 PARKINSON^S DISEASE 45
768 SEPTIC SHOCK 45
769 SLEEP TALKING 45
770 SPINAL OSTEOARTHRITIS 45
771 ATELECTASIS 44
772 BLOOD PRESSURE DIASTOLIC INCREASED 44
773 FOOD CRAVING 44
774 GASTRIC BYPASS 44
775 HEPATITIS 44
776 INTRAOCULAR PRESSURE INCREASED 44
777 LEUKOCYTOSIS 44
778 MUSCULOSKELETAL CHEST PAIN 44
779 NEOPLASM MALIGNANT 44
780 PAIN OF SKIN 44
781 PRODUCT PRESCRIBING ISSUE 44
782 PRURITUS GENERALISED 44
783 TYPE 1 DIABETES MELLITUS 44
784 ABDOMINAL PAIN LOWER 43
785 ADVERSE REACTION 43
786 BLEPHAROSPASM 43
787 GAMBLING DISORDER 43
788 HYPERACUSIS 43
789 HYPERLIPIDAEMIA 43
790 HYPERREFLEXIA 43
791 LOSS OF LIBIDO 43
792 MENSTRUAL DISORDER 43
793 OSTEOMYELITIS 43
794 PERSECUTORY DELUSION 43
795 PREMATURE BABY 43
796 STARING 43
797 TORTICOLLIS 43
798 AGEUSIA 42
799 BRONCHOSPASM 42
800 BUNDLE BRANCH BLOCK RIGHT 42
801 DEVICE DIFFICULT TO USE 42
802 EXCESSIVE EYE BLINKING 42
803 HAEMATOMA 42
804 LYMPHOPENIA 42
805 MIOSIS 42
806 NEUROLOGICAL SYMPTOM 42
807 OCULOGYRIC CRISIS 42
808 OVERWEIGHT 42
809 PHARYNGEAL SWELLING 42
810 PRODUCT ODOUR ABNORMAL 42
811 PULMONARY CONGESTION 42
812 SCRATCH 42
813 SKIN HAEMORRHAGE 42
814 SKIN ULCER 42
815 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 42
816 ABNORMAL LOSS OF WEIGHT 41
817 CANDIDA INFECTION 41
818 CHOREA 41
819 DERMATILLOMANIA 41
820 DEVICE EXPULSION 41
821 DEVICE RELATED INFECTION 41
822 DYSPHORIA 41
823 ENDOMETRIOSIS 41
824 FAECES DISCOLOURED 41
825 FEELING OF DESPAIR 41
826 FLAT AFFECT 41
827 LUNG CYST 41
828 NERVE INJURY 41
829 OROMANDIBULAR DYSTONIA 41
830 SINUS BRADYCARDIA 41
831 TEARFULNESS 41
832 ACUTE RESPIRATORY FAILURE 40
833 ANXIETY DISORDER 40
834 ARTHROPOD BITE 40
835 AUTOIMMUNE THYROIDITIS 40
836 CLOSTRIDIUM DIFFICILE COLITIS 40
837 CLUMSINESS 40
838 DEPERSONALISATION/DEREALISATION DISORDER 40
839 ERUCTATION 40
840 FEMUR FRACTURE 40
841 HEAVY MENSTRUAL BLEEDING 40
842 HYPERAESTHESIA 40
843 INCORRECT PRODUCT ADMINISTRATION DURATION 40
844 INFUSION SITE PAIN 40
845 JOINT DISLOCATION 40
846 NEOPLASM PROGRESSION 40
847 OBSTRUCTIVE SLEEP APNOEA SYNDROME 40
848 PRESCRIBED UNDERDOSE 40
849 SKIN FISSURES 40
850 CHOLECYSTITIS CHRONIC 39
851 COMMUNICATION DISORDER 39
852 CONJUNCTIVITIS 39
853 CORONARY ARTERY DISSECTION 39
854 DECREASED ACTIVITY 39
855 DEVICE USE ERROR 39
856 DIABETIC KETOACIDOSIS 39
857 DYSMENORRHOEA 39
858 GASTROINTESTINAL PAIN 39
859 HYPERTENSIVE CRISIS 39
860 HYPERTONIC BLADDER 39
861 INJECTION SITE MASS 39
862 LARYNGITIS 39
863 PERSONALITY DISORDER 39
864 PRODUCT SUPPLY ISSUE 39
865 SJOGREN^S SYNDROME 39
866 STRESS CARDIOMYOPATHY 39
867 VITAMIN B12 DEFICIENCY 39
868 WEIGHT FLUCTUATION 39
869 APPLICATION SITE PRURITUS 38
870 EAR DISCOMFORT 38
871 HALLUCINATION, TACTILE 38
872 HEPATIC FAILURE 38
873 HYPOTONIA 38
874 LIBIDO INCREASED 38
875 LOCALISED INFECTION 38
876 MALABSORPTION 38
877 PERONEAL NERVE PALSY 38
878 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 38
879 PRODUCT COMPLAINT 38
880 PSYCHOTIC SYMPTOM 38
881 SEDATION COMPLICATION 38
882 SHOULDER OPERATION 38
883 SOCIAL PROBLEM 38
884 SPINAL FUSION SURGERY 38
885 SUSPECTED SUICIDE 38
886 TASTE DISORDER 38
887 TOOTH ABSCESS 38
888 ANKYLOSING SPONDYLITIS 37
889 APPLICATION SITE PAIN 37
890 AUTONOMIC NERVOUS SYSTEM IMBALANCE 37
891 BLOOD IRON DECREASED 37
892 BLOOD LACTATE DEHYDROGENASE INCREASED 37
893 COMPULSIVE SHOPPING 37
894 FACIAL PAIN 37
895 GOUT 37
896 LACTIC ACIDOSIS 37
897 LEFT VENTRICULAR DYSFUNCTION 37
898 NEEDLE ISSUE 37
899 OCULAR DISCOMFORT 37
900 OVARIAN CYST 37
901 PARTIAL SEIZURES 37
902 RESPIRATORY TRACT MALFORMATION 37
903 SENSATION OF FOREIGN BODY 37
904 SKIN REACTION 37
905 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 37
906 SPINAL DISORDER 37
907 TONSILLITIS 37
908 UNDERWEIGHT 37
909 UVEITIS 37
910 ACUTE RESPIRATORY DISTRESS SYNDROME 36
911 BEDRIDDEN 36
912 BLOOD THYROID STIMULATING HORMONE INCREASED 36
913 CEREBRAL DISORDER 36
914 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36
915 DEVICE DISLOCATION 36
916 ECCHYMOSIS 36
917 FRUSTRATION 36
918 HYPOTHERMIA 36
919 MULTIPLE DRUG OVERDOSE 36
920 OSTEONECROSIS 36
921 PRODUCT RESIDUE PRESENT 36
922 RESPIRATORY TRACT CONGESTION 36
923 SENSORY LOSS 36
924 SKIN INFECTION 36
925 TROPONIN INCREASED 36
926 BIPOLAR I DISORDER 35
927 BRAIN NEOPLASM 35
928 CARDIOMEGALY 35
929 CONGESTIVE CARDIOMYOPATHY 35
930 DECREASED EYE CONTACT 35
931 ELECTROENCEPHALOGRAM ABNORMAL 35
932 FAILURE TO THRIVE 35
933 IMMUNODEFICIENCY 35
934 INJECTION SITE URTICARIA 35
935 JAW DISORDER 35
936 LIQUID PRODUCT PHYSICAL ISSUE 35
937 METASTASES TO BONE 35
938 MUSCLE ATROPHY 35
939 PLATELET COUNT INCREASED 35
940 RENAL INJURY 35
941 SARS-COV-2 TEST POSITIVE 35
942 SECRETION DISCHARGE 35
943 SLEEP TERROR 35
944 SPINAL FRACTURE 35
945 TUBULOINTERSTITIAL NEPHRITIS 35
946 VENTRICULAR FIBRILLATION 35
947 WRIST FRACTURE 35
948 BLOOD SODIUM DECREASED 34
949 DYSGRAPHIA 34
950 ERECTION INCREASED 34
951 FOOT DEFORMITY 34
952 HYPERTONIA 34
953 IRON DEFICIENCY ANAEMIA 34
954 LACERATION 34
955 LYME DISEASE 34
956 MALNUTRITION 34
957 NEUTROPHIL COUNT INCREASED 34
958 ORAL CANDIDIASIS 34
959 PELVIC PAIN 34
960 PERICARDIAL EFFUSION 34
961 POLYDIPSIA 34
962 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 34
963 SPINAL PAIN 34
964 STEREOTYPY 34
965 STRABISMUS 34
966 THERAPEUTIC PRODUCT EFFECT DELAYED 34
967 TOOTH FRACTURE 34
968 ASPIRATION 33
969 AUTOIMMUNE DISORDER 33
970 DIZZINESS POSTURAL 33
971 FACE OEDEMA 33
972 FOOD POISONING 33
973 GLYCOSYLATED HAEMOGLOBIN INCREASED 33
974 HEPATOMEGALY 33
975 OSTEONECROSIS OF JAW 33
976 PHYSICAL ASSAULT 33
977 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 33
978 PROTEIN URINE PRESENT 33
979 RHINITIS ALLERGIC 33
980 UPPER-AIRWAY COUGH SYNDROME 33
981 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 32
982 ALCOHOL ABUSE 32
983 BONE DENSITY DECREASED 32
984 BREAST MASS 32
985 CHOLESTASIS 32
986 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32
987 HEMIPLEGIA 32
988 HEPATIC CYTOLYSIS 32
989 HYPERSEXUALITY 32
990 IMMUNE SYSTEM DISORDER 32
991 INFUSION SITE SWELLING 32
992 ISCHAEMIC STROKE 32
993 PAPILLOEDEMA 32
994 PETECHIAE 32
995 PLASMA CELL MYELOMA 32
996 POLYURIA 32
997 POOR VENOUS ACCESS 32
998 RETINAL DETACHMENT 32
999 SCAB 32